Oriental Aromatics Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.

Profit growth above 25%EBITDA margin expansionNegative operating cash flowResults View source PDF Explain this filing

OAL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-10.9%Reaction day

₹430.00

prior close

₹403.10

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.3%-11.2% vs market

Specialty Chemicals peers, median of 81sector-0.1%-10.8% vs sector

On the reaction day the stock moved 11.2 pts less than Nifty Microcap 250 and 10.8 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.2

10m

-2.5

15m

-1.9

30m

-1.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-10.9+0.3-11.2-0.1-10.8

Next day

-14.0+0.7-14.6+0.2-14.1

-15.6+1.0-16.5-0.5-15.1

-14.8+1.1-15.9+0.3-15.1

-14.2+0.8-14.9-0.2-14.0

-12.9+1.3-14.2+1.2-14.2

-10.2+1.7-12.0+1.7-11.9

15d

-9.5+1.5-11.0+0.1-9.6

-12.1+4.0-16.1+2.4-14.5

-13.3+1.8-15.1+0.7-14.0

-23.1-1.0-22.1-2.3-20.8

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 81Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Oriental Aromatics Limited reported audited FY25 results with standalone revenue from operations rising to ₹92,797.18 lakh from ₹83,640.47 lakh (about 11% YoY growth), while standalone net profit jumped sharply to ₹4,683.55 lakh from ₹948.18 lakh (nearly 5x YoY). On a consolidated basis, revenue grew to ₹92,825.62 lakh and net profit climbed to ₹3,432.83 lakh versus ₹910.42 lakh, supported by margin expansion as total expenses grew more slowly than revenue. The subsidiary Oriental Aromatics & Sons commenced commercial production in November 2024 and is currently loss-making, dragging on consolidated profits. The Board has recommended a final dividend of ₹0.50 per share (10% on face value of ₹5), with record date August 8, 2025 and AGM on August 21, 2025. Statutory auditor Lodha & Co LLP issued an unmodified opinion on the results.

Likely market impact

Strong earnings growth and EBITDA margin expansion are positive for shareholders, and the modest dividend signals returning cash to investors. However, both standalone and consolidated operating cash flows turned sharply negative (₹(1,852) lakh and ₹(3,429) lakh respectively) due to a large inventory build-up, which warrants monitoring despite the bottom-line improvement.